Centrallink: Your Trusted Global Source for Infectious Disease Biospecimens
Infectious disease research plays a critical role in global public health, driving advancements in diagnostics, therapeutics, epidemiology, and vaccine development. Researchers depend on well-characterized biospecimens that accurately capture host-pathogen interactions, immune responses, antibody production, and biomarker patterns. Centrallink supports this essential work through a robust library of infectious disease biospecimens sourced from accredited clinical sites and biobanks worldwide.
Our inventory includes serum, plasma, whole blood, swabs, tissues, PBMCs, DNA, RNA, and other materials from donors exposed to viral, bacterial, fungal, and parasitic pathogens. Every biospecimen is collected under strict ethical oversight, ensuring high-quality material suitable for research, assay development, serological testing, pathogen detection, and translational immunology.
Extensive Pathogen Coverage for Advanced Research
Centrallink offers biospecimens associated with a wide range of infectious agents, including respiratory viruses, bloodborne pathogens, gastrointestinal infections, vector-borne diseases, bacterial infections, and emerging pathogens. Available pathogen categories may include influenza, RSV, SARS-CoV-2, HBV, HCV, HIV, CMV, EBV, dengue, chikungunya, malaria, tuberculosis, and many more. These diverse samples support studies in epidemiology, immunology, pathogen genomics, and diagnostic assay validation.
Samples are accompanied by relevant clinical and laboratory information, such as antibody titers, antigen positivity, viral load, serotype, culture results, PCR data, and diagnostic history. This ensures that researchers can select biospecimens that precisely match their experimental needs.
Streamlined Procurement with Global Reach
Centrallink streamlines infectious disease biospecimen procurement through an intuitive digital platform that enables fast, accurate sample identification. Researchers can filter by pathogen type, serostatus, disease progression, sample type, donor demographics, and clinical parameters to quickly find the most relevant specimens. Real-time inventory transparency and clear catalog data support efficient decision-making.
For specialized study requirements—such as matched cohorts, high-titer antibody samples, acute versus convalescent samples, or rare pathogen profiles—Centrallink provides custom sourcing services. Our scientific support team collaborates with accredited collection partners to fulfill unique infectious disease research needs.
Supporting Breakthroughs in Diagnostics, Vaccines, and Global Health
High-quality infectious disease biospecimens are essential for advancing global health research. Centrallink supports diagnostic developers, vaccine researchers, epidemiologists, and academic laboratories by providing samples suitable for serology testing, molecular detection, pathogen sequencing, biomarker validation, and multi-omics workflows.
Through ethical sourcing, comprehensive clinical annotation, and a technologically advanced procurement system, Centrallink helps researchers accelerate discoveries that combat global infectious threats. Whether your research focuses on emerging pathogens, chronic infections, or immune response characterization, our platform ensures reliable, fast, and high-quality biospecimen access.